Neo-adjuvant chemotherapy in mucinous breast cancer: Is it of clinical added value?

被引:0
|
作者
Granzier, R. [1 ,2 ,3 ]
Van Nijnatten, T. [2 ,3 ]
Engelen, S. [1 ]
De Munck, L. [4 ]
Siesling, S. [4 ,5 ]
Smidt, M. [1 ,2 ]
机构
[1] Maastricht Univ, Med Ctr, Surg, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, Radiol & Nucl Med, Maastricht, Netherlands
[4] Netherlands Comprehens Canc Org, Res, Utrecht, Netherlands
[5] Univ Twente, Dept Hlth Technol & Serv Res, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
355 (PB-15
引用
收藏
页码:S99 / S100
页数:2
相关论文
共 50 条
  • [41] Neo-adjuvant Chemotherapy for triple-negative breast cancer: a place for platinum?
    Goncalves, Anthony
    BULLETIN DU CANCER, 2014, 101 (12) : 1063 - 1063
  • [42] NEO-ADJUVANT CHEMOTHERAPY IN ONCOLOGY
    HOERNI, B
    CHAUVERGNE, J
    RAVAUD, A
    GAZETTE MEDICALE, 1989, 96 (20): : 49 - &
  • [43] Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy
    D'Hondt, Cynthia
    Vanhoeij, Marian
    Van Moer, Ellen
    Segers, Ingrid
    Fontaine, Christel
    Tournaye, Herman
    De Vos, Michel
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (02) : 433 - 444
  • [44] Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy
    Cynthia D’Hondt
    Marian Vanhoeij
    Ellen Van Moer
    Ingrid Segers
    Christel Fontaine
    Herman Tournaye
    Michel De Vos
    Breast Cancer Research and Treatment, 2020, 184 : 433 - 444
  • [45] The predictive value of sentinel node biopsy in early breast cancer after neo-adjuvant chemotherapy: A prospective study
    Najim, Omar
    Dockx, Yanina
    Huyghe, Ivan
    van den Wyngaert, Tim
    Papadimitriou, Konstantinos
    Tjalma, Wiebren A. A.
    Huizing, Manon T.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 229 : 108 - 111
  • [46] Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy
    Kim, SJ
    Kim, SK
    Lee, ES
    Ro, J
    Kang, SH
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1352 - 1357
  • [47] Localized invasive bladder cancer: neo-adjuvant chemotherapy?
    Bellmunt, J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S1 - S3
  • [48] Selection of patients with oesophageal cancer for neo-adjuvant chemotherapy
    O'Donohoe, L
    Morrison, JJ
    Graham, L
    Deans, C
    de Beaux, AC
    Paterson-Brown, S
    BRITISH JOURNAL OF SURGERY, 2003, 90 : 126 - 127
  • [49] Neo-adjuvant Chemotherapy Improves Survival Compared to Neo-adjuvant Radio-Chemotherapy Among Gastric Cardia Cancer Patients
    Tsai, C.
    Muller, A.
    Warschkow, R.
    Nussbaum, D. P.
    Bruno, S.
    Gloor, B.
    Blazer, D. G.
    Worni, M.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S204 - S204
  • [50] Does response to neo-adjuvant chemotherapy impact breast reconstruction?
    Cassidy, Michael R.
    Zabor, Emily C.
    Stempel, Michelle
    Mehrara, Babak
    Gemignani, Mary L.
    BREAST JOURNAL, 2018, 24 (04): : 567 - 573